DC Chemicals

All products / DC12273

EMT inhibitor-1
CAT. NO. DC12273

EMT inhibitor-1

Pack sizes and prices

Pack sizePrice
100 mg$950 USDRequest a quote / confirm availability →
250 mg$1,900 USDRequest a quote / confirm availability →
1 g$3,800 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

In Vitro EMT inhibitor-1 (C19) is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities, inhibiting cancer cell migration, proliferation, and resistance to doxorubicin in vitro. In Vivo EMT inhibitor-1 (C19) exerts strong antitumor activity in a mouse tumor model. Mechanistically, EMT inhibitor-1 induces GSK3-β–mediated degradation of the Hippo transducer TAZ, through activation of the Hippo kinases Mst/Lats and the tumor suppressor kinase AMPK upstream of the degradation complex.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC12273
Product nameEMT inhibitor-1
CAS1638526-21-2
Molecular formulaC12H12Cl2N2O2S
Molecular weight319.21
Purity>98%
SMILESOCCCCOc1nsnc1-c1ccc(Cl)c(Cl)c1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — EMT inhibitor-1 (DC12273)

Related research products

Browse newly added products